Montag & Associates’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-75
| Closed | -$3.39K | – | 923 |
|
|
2023
Q1 | $3.39K | Sell |
75
-100
| -57% | -$4.52K | ﹤0.01% | 836 |
|
|
2022
Q4 | $7.11K | Sell |
175
-100
| -36% | -$4.07K | ﹤0.01% | 780 |
|
|
2022
Q3 | $18K | Sell |
275
-733
| -73% | -$48K | ﹤0.01% | 670 |
|
|
2022
Q2 | $61K | Sell |
1,008
-860
| -46% | -$52K | ﹤0.01% | 503 |
|
|
2022
Q1 | $117K | Sell |
1,868
-436
| -19% | -$27.3K | 0.01% | 444 |
|
|
2021
Q4 | $175K | Sell |
2,304
-1,969
| -46% | -$150K | 0.01% | 402 |
|
|
2021
Q3 | $478K | Buy |
4,273
+79
| +2% | +$8.84K | 0.03% | 299 |
|
|
2021
Q2 | $679K | Buy |
4,194
+102
| +2% | +$16.5K | 0.04% | 264 |
|
|
2021
Q1 | $499K | Sell |
4,092
-210
| -5% | -$25.6K | 0.03% | 292 |
|
|
2020
Q4 | $659K | Buy |
4,302
+272
| +7% | +$41.7K | 0.04% | 242 |
|
|
2020
Q3 | $337K | Buy |
+4,030
| New | +$337K | 0.03% | 258 |
|